② According to the documents disclosed by HKEX on June 24th,$TENCENT (00700.HK)$, $MEITUAN-W (03690.HK)$And so on to repurchase shares.
Please use your Futubull account to access the feature.$TENCENT (00700.HK)$It repurchased 2.63 million shares of common stock on June 21, involving HKD 1.004 billion, with a repurchase price ranging from HKD 385 to 378.4 per share.
Since the repurchase authorization resolution, the cumulative number of repurchased securities is 64.56 million shares, accounting for 0.685% of the number of issued shares when the ordinary resolution was passed.
Repurchased 3.394 million ordinary shares on May 31, involving an amount of HKD234 million, with a repurchase price per share ranging from HKD69.1 to HKD68.55.$MEITUAN-W (03690.HK)$It repurchased 4.2831 million shares of common stock on June 21, involving HKD 500 million, with a repurchase price ranging from HKD 119.9 to 114.1 per share.
Since the repurchase authorization resolution, the cumulative number of repurchased securities is 17.7421 million shares, accounting for 0.285% of the number of issued shares when the ordinary resolution was passed.
Repurchased 1 million ordinary shares on June 3, involving an amount of HKD60.6193 million, with a repurchase price per share ranging from HKD61.15 to HKD59.8.$HSBC HOLDINGS (00005.HK)$It repurchased 2.6228 million shares of common stock on June 20, involving HKD 180 million, with a repurchase price ranging from HKD 68.8 to 68.3 per share.
Asymchem Laboratories (06821.HK)$AIA (01299.HK)$It repurchased 1.1574 million shares of common stock on June 21, involving HKD 64.1952 million, with a repurchase price ranging from HKD 56.05 to 55.05 per share.
Since the repurchase authorization resolution, the cumulative number of repurchased securities is 75.4982 million shares, accounting for 0.672% of the number of issued shares when the ordinary resolution was passed.
Repurchased 2.8 million weighted voting right shares on June 3, involving an amount of HKD50.0474 million, with a repurchase price per share ranging from HKD17.94 to HKD17.82.$CSPC PHARMA (01093.HK)$It repurchased 10 million shares of common stock on June 21, involving HKD 63.6134 million, with a repurchase price ranging from HKD 6.45 to 6.31 per share.
Since the repurchase authorization resolution, the cumulative number of repurchased securities is 10 million shares, accounting for 0.084% of the number of issued shares when the ordinary resolution was passed.
Details of share buybacks by listed companies can be found in the figure below:
What is share buyback?
Share buyback refers to a behavior of listed companies using cash to repurchase a certain amount of outstanding shares on the stock market. After the share buyback, the company can cancel the repurchased shares. This will reduce the number of outstanding shares in circulation, thus achieving positive effects such as market cap management, stock-based incentive, and stable stock price.